Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.
Animals
Antibodies, Monoclonal
/ chemistry
Antigens, Bacterial
/ genetics
Bacterial Proteins
/ genetics
Complement Factor H
/ genetics
Crystallography, X-Ray
Epitopes
/ genetics
Genetic Variation
Humans
Meningococcal Infections
/ microbiology
Meningococcal Vaccines
/ administration & dosage
Models, Molecular
Neisseria meningitidis
/ drug effects
Protein Binding
Protein Conformation
Neisseria meningitidis
fHbp
human antibodies
vaccine
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
24
8
2019
medline:
9
6
2020
entrez:
24
8
2019
Statut:
ppublish
Résumé
The 4 component meningococcus B vaccine (4CMenB) vaccine is the first vaccine containing recombinant proteins licensed for the prevention of invasive meningococcal disease caused by meningococcal serogroup B strains. 4CMenB contains 3 main recombinant proteins, including the
Identifiants
pubmed: 31442074
doi: 10.1096/fj.201900374R
pmc: PMC6902690
doi:
Substances chimiques
4CMenB vaccine
0
Antibodies, Monoclonal
0
Antigens, Bacterial
0
Bacterial Proteins
0
Epitopes
0
Meningococcal Vaccines
0
factor H-binding protein, Neisseria meningitidis
0
Complement Factor H
80295-65-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12099-12111Références
FASEB J. 2014 Apr;28(4):1644-53
pubmed: 24371123
Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S103-S112
pubmed: 27129415
Biologicals. 2000 Sep;28(3):193-7
pubmed: 10964447
Expert Rev Vaccines. 2015;14(9):1277-87
pubmed: 26204792
Arch Pediatr Adolesc Med. 2005 Oct;159(10):907-13
pubmed: 16203934
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
Vaccine. 2003 Jun 1;21 Suppl 2:S110-3
pubmed: 12763692
Lancet. 2007 Jun 30;369(9580):2196-2210
pubmed: 17604802
Clin Infect Dis. 2010 Nov 15;51(10):1127-37
pubmed: 20954968
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3304-9
pubmed: 23396847
Structure. 2016 Jan 5;24(1):148-157
pubmed: 26712277
J Infect Dis. 2013 Aug 15;208(4):627-36
pubmed: 23715659
Curr Opin Microbiol. 2015 Feb;23:68-72
pubmed: 25461575
PLoS One. 2012;7(3):e34272
pubmed: 22461909
J Exp Med. 2003 Mar 17;197(6):789-99
pubmed: 12642606
Expert Rev Vaccines. 2011 May;10(5):617-34
pubmed: 21604983
Infect Immun. 2011 Feb;79(2):970-81
pubmed: 21149595
mBio. 2014 Aug 26;5(5):e01625-14
pubmed: 25161192
Methods Mol Med. 2001;67:333-9
pubmed: 21337154
J Mol Biol. 1997 Nov 7;273(4):927-48
pubmed: 9367782
Infect Immun. 2011 Sep;79(9):3751-9
pubmed: 21708990
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
Infect Immun. 2012 Jan;80(1):187-94
pubmed: 22064712
Lancet. 2016 Dec 3;388(10061):2775-2782
pubmed: 28100432
PLoS Pathog. 2012;8(10):e1002981
pubmed: 23133374
Vaccine. 2009 May 26;27(25-26):3417-21
pubmed: 19200847
J Mol Biol. 2009 Feb 13;386(1):97-108
pubmed: 19100746
Sci Rep. 2018 Feb 27;8(1):3700
pubmed: 29487324
Int J Epidemiol. 2001 Dec;30(6):1447-8
pubmed: 11821361
J Immunol. 2006 Jun 15;176(12):7566-75
pubmed: 16751403
J Immunol. 2006 Jul 1;177(1):501-10
pubmed: 16785547
Mech Ageing Dev. 2007 Jan;128(1):161-7
pubmed: 17126887
Clin Vaccine Immunol. 2010 Jun;17(6):919-29
pubmed: 20375242
Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14823-8
pubmed: 26627237
Methods Mol Biol. 2012;799:1-20
pubmed: 21993636
Biochem J. 2016 Dec 15;473(24):4699-4713
pubmed: 27784765
Nat Commun. 2018 Feb 6;9(1):528
pubmed: 29410413
Clin Epidemiol. 2012;4:237-45
pubmed: 23071402
Infect Immun. 2015 Apr;83(4):1536-45
pubmed: 25644002
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17128-33
pubmed: 25404323
Sci Rep. 2016 Aug 17;6:31458
pubmed: 27530334
mBio. 2015 Jun 23;6(3):e00842
pubmed: 26106082
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 May 1;67(Pt 5):531-5
pubmed: 21543855
J Immunol. 1987 Jun 15;138(12):4402-7
pubmed: 3108388
Vaccine. 2011 Jun 24;29(29-30):4728-34
pubmed: 21571025
Sci Rep. 2012;2:341
pubmed: 22461972
Science. 2001 Aug 10;293(5532):1155-9
pubmed: 11498595
J Mol Biol. 2006 Apr 14;357(5):1566-74
pubmed: 16497332
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2714-9
pubmed: 26888286
Expert Rev Vaccines. 2011 Jan;10(1):21-33
pubmed: 21162617
Infect Immun. 2005 Feb;73(2):1151-60
pubmed: 15664958
J Biol Chem. 2009 Apr 3;284(14):9022-6
pubmed: 19196709
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Nature. 2009 Apr 16;458(7240):890-3
pubmed: 19225461
Expert Opin Pharmacother. 2004 Apr;5(4):855-63
pubmed: 15102568
Vaccine. 2013 Mar 15;31(12):1569-75
pubmed: 23352429
Mol Immunol. 2008 Jul;45(12):3477-89
pubmed: 18023478
Biochim Biophys Acta. 2010 Feb;1798(2):87-93
pubmed: 19835839
Infect Immun. 2008 Sep;76(9):4232-40
pubmed: 18591239
Trends Biochem Sci. 2010 Oct;35(10):539-46
pubmed: 20541943